Post-market safety warnings for drugs approved in Canada under the Notice of Compliance with conditions policy
Author:
Affiliation:
1. School of Health Policy and Management; York University; 4700 Keele St. Toronto Ontario Canada M3J 1P3
Publisher
Wiley
Subject
Pharmacology (medical),Pharmacology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/bcp.12552/fullpdf
Reference19 articles.
1. Health Canada: Health Products and Food Branch Guidance for industry: priority review of drug submissions 2009
2. Health Products and Food Branch Guidance document: notice of compliance with conditions (NOC/c) 2011
Cited by 30 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Lessons from Canada’s notice of compliance with conditions policy for the life-cycle regulation of drugs;Journal of Law and the Biosciences;2023-01-01
2. Information about confirmatory studies required for new drugs conditionally approved by Health Canada: A cross-sectional study;PLOS ONE;2022-10-20
3. Conditional Drug Approval as a Path to Market for Oncology Drugs in Canada: Challenges and Recommendations for Assessing Eligibility and Regulatory Responsiveness;Frontiers in Medicine;2022-02-03
4. Postmarketing safety of orphan drugs: a longitudinal analysis of the US Food and Drug Administration database between 1999 and 2018;Orphanet Journal of Rare Diseases;2022-01-04
5. Can adaptive clinical trials help to solve the productivity crisis of the pharmaceutical industry? - a scenario analysis;Health Economics Review;2021-01-16
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3